Prognosis significance of Ki-67 expression for patients with laryngeal squamous cell carcinoma primarily treated by total laryngectomy

European Archives of Oto-Rhino-Laryngology

Volumn 261, Issue 7, 2004, Pages 376-380

  Acikalin, Mustafa Fuat ^a,b   Öner, Ülkü ^a   Tel, Nilüfer ^a   Pasa̧oǧlu, Özgül ^a   Çakli, Hamdi ^a   Çolak, Ertuǧrul ^a  

^a OSMANGAZI UNIVERSITY MEDICAL FACULTY   (Turkey)

^b Gultepe Mh Universitesi Evleri   (Turkey)

Author keywords

Ki 67; Laryngeal carcinoma; Prognosis

Indexed keywords

KI 67 ANTIGEN;

ADULT; AGE DISTRIBUTION; AGED; ANTIBODY LABELING; ARTICLE; CANCER GRADING; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; CELL PROLIFERATION; CLINICAL FEATURE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE MARKER; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; KAPLAN MEIER METHOD; LABELING INDEX; LARYNGECTOMY; LARYNX CARCINOMA; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA; SURVIVAL RATE; CELL DIVISION; CHEMISTRY; LARYNX TUMOR; METASTASIS; MIDDLE AGED; PATHOLOGY; TUMOR RECURRENCE;

ADULT; AGED; CARCINOMA, SQUAMOUS CELL; CELL DIVISION; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; LARYNGEAL NEOPLASMS; LARYNGECTOMY; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS;

EID: 4344570759     PISSN: 09374477     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00405-003-0699-3     Document Type: Article

References (20)

1. Aaltomaa S, Lipponen P, Ala-Opas M, Eskelinen M, Syrjanen K (1997) Prognostic value of Ki-67 expression in renal cell carcinomas. Eur Urol 31:350-355
2. Deshmukh P, Ramsey L, Garewal HS (1990) Ki-67 labeling index is a more reliable measure of solid tumor proliferative activity than tritiated thymidine labeling. Am J Clin Pathol 94:192-195
3. Gallo O, Libonati GA, Gallina E, Fini-Storchi O, Giannini A, Urso C, Bondi R (1991) Langerhans cells related to prognosis in patients with laryngeal carcinoma. Arch Otolaryngol Head Neck Surg 117:1007-1010
4. Golusinski W, Olofsson J, Szmeja Z, Majewski P (1996) P53, PCNA and Ki-67 in laryngeal cancer. Pol J Pathol 47:175-182
5. Grzanka A, Sujkowska R, Janiak A, Adamska M (2000) Immunogold labelling of PCNA and Ki-67 antigen at the ultrastructural level in laryngeal squamous cell carcinoma and its correlation with lymph node metastasis and histological grade. Acta Histochem 102:139-149
6. Hagedorn HG, Tubel J, Wiest I, Nerlich AG (1998) In situ apoptotic and proliferation index in laryngeal squamous cell carcinomas. Anal Cell Pathol 16:177-184
7. Holte H, de Lange Davies C, Beiske K, Stokke T, Marton PF, Smeland EB, Hoie J, Kvaloy S (1989) Ki-67 and 4F2 antigen expression as well as DNA synthesis predict survival at relapse/tumor progression in low-grade B-cell lymphoma. Int J Cancer 44:975-980
8. Kamel OW, Franklin WA, Ringus JC, Meyer JS (1989) Thymidin labeling index and Ki-67 growth fraction in lesions of the breast. Am J Pathol 134:107-113
9. Lazaris AC, Rigopoulou A, Tseleni-Balafouta S, Kavantzas N, Thimara I, Zorzos HS, Eutychiadis CA, Petraki K, Kandiloros D, Davaris P (2002) Immunodetection and clinico-pathological correlates of two tumour growth regulators in laryngeal carcinoma. Histol Histopathol 17:131-138
10. Pera E, Moreno A, Galindo L (1986) Prognostic factors in laryngeal carcinoma: A multifactorial study of 416 cases. Cancer 58:928-934
11. Perez Carro Rios A, Garcia Caballero T, Lozano Ramirez A, Arias Santos MD, Soto Varela A, Forteza Vila J, Labella Caballero T (2000) The relationship between survival and cell proliferation index in squamous cell carcinoma of larynx. Rev Laryngol Otol Rhinol (Bord) 121:121-125
12. Pradier R, Gonzalez A, Matos E, Loria D, Adan R, Saco P, Califano L (1993) Prognostic factors in laryngeal carcinoma: Experience in 296 male patients. Cancer 71:2472-2476
13. Pulkkinen JO, Penttinen M, Jalkanen M, Klemi P, Grenman R (1997) Syndecan-1: a new prognostic marker in laryngeal cancer. Acta Otolaryngol 117:312-315
14. Sittel C, Eckel HE, Damm M, von Pritzbuer E, Kvasnicka HM (2000) Ki-67 (MIB-1), p53, and Lewis-X (LeuM1) as prognostic factors of recurrence in T1 and T2 laryngeal carcinoma. Laryngoscope 110:1012-1017
15. Spafford MF, Koeppe J, Pan Z, Archer PG, Meyers AD, Franklin WA (1996) Correlation of tumor markers p53, bcl-2, CD34, Cd44H, CD44v6, and Ki-67 with survival and metastasis in laryngeal squamous cell carcinoma. Arch Otolaryngol Head Neck Surg 122:627-632
16. Taxy JB (1996) Upper respiratory tract. In: Damjanov I, Linder J (eds) Anderson's pathology, 10th edn. Mosby, St. Louis, p 1463
17. Tungekar MF, Gatter KC, Dunnill MS, Masan DY (1991) Ki-67 immunostaining and survival in operable lung cancer. Histopathology 19:545-550
18. Twentyman RR (1988) Radiation response of tumours: Experimental. In: Bleehen NM (ed). Radiobiology in radiotherapy. Springer, Heidelberg Berlin New York, pp 9-15
19. Wintzer HO, Zipfel I, Schulte-Mönting J, Hellerich U, von Kleist S (1991) Ki-67 immunostaining of human breast tumors and its relationship to prognosis. Cancer 67:421-428
20. Youssef EM, Matsuda T, Takada N, Osugi H, Higashino M, Kinoshita H, Watanabe T, Katsura Y, Wanibushi H, Fukushima S (1995) Prognostic significance of the MIB-1 proliferation index for patients with squamous cell carcinoma of the esophagus. Cancer 76:358-366